NO307916B1 - Anvendelse av en progesteronreseptorantagonist og kit med innhold derav - Google Patents

Anvendelse av en progesteronreseptorantagonist og kit med innhold derav

Info

Publication number
NO307916B1
NO307916B1 NO953242A NO953242A NO307916B1 NO 307916 B1 NO307916 B1 NO 307916B1 NO 953242 A NO953242 A NO 953242A NO 953242 A NO953242 A NO 953242A NO 307916 B1 NO307916 B1 NO 307916B1
Authority
NO
Norway
Prior art keywords
receptor antagonist
progesterone receptor
kit
preventing
oocyte
Prior art date
Application number
NO953242A
Other languages
English (en)
Other versions
NO953242D0 (no
NO953242L (no
Inventor
Gary D Hodgen
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Publication of NO953242D0 publication Critical patent/NO953242D0/no
Publication of NO953242L publication Critical patent/NO953242L/no
Publication of NO307916B1 publication Critical patent/NO307916B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Steroid Compounds (AREA)
  • Fertilizers (AREA)
  • Fats And Perfumes (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO953242A 1993-02-19 1995-08-17 Anvendelse av en progesteronreseptorantagonist og kit med innhold derav NO307916B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization
PCT/US1994/001804 WO1994018982A1 (en) 1993-02-19 1994-02-18 Method of preventing or inhibiting fertilization

Publications (3)

Publication Number Publication Date
NO953242D0 NO953242D0 (no) 1995-08-17
NO953242L NO953242L (no) 1995-08-17
NO307916B1 true NO307916B1 (no) 2000-06-19

Family

ID=21795040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953242A NO307916B1 (no) 1993-02-19 1995-08-17 Anvendelse av en progesteronreseptorantagonist og kit med innhold derav

Country Status (24)

Country Link
US (1) US5516769A (no)
EP (2) EP1159965B1 (no)
JP (1) JP3054780B2 (no)
KR (1) KR100232833B1 (no)
AT (2) ATE286734T1 (no)
AU (1) AU692150B2 (no)
BG (1) BG62431B1 (no)
BR (1) BR9406666A (no)
CA (1) CA2156493C (no)
CZ (1) CZ294325B6 (no)
DE (2) DE69434239T2 (no)
DK (2) DK1159965T3 (no)
ES (1) ES2231356T3 (no)
FI (1) FI114687B (no)
HU (1) HU221162B1 (no)
NO (1) NO307916B1 (no)
NZ (1) NZ262998A (no)
PL (1) PL175440B1 (no)
PT (2) PT684825E (no)
RO (1) RO118565B1 (no)
RU (1) RU2139055C1 (no)
SK (1) SK282068B6 (no)
UA (1) UA41351C2 (no)
WO (1) WO1994018982A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
CO5190694A1 (es) 1999-08-31 2002-08-29 Jenapharm Gmbh And Co Kg Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
UA41351C2 (uk) 2001-09-17
CA2156493C (en) 2002-10-29
BR9406666A (pt) 1996-01-23
NO953242D0 (no) 1995-08-17
BG62431B1 (bg) 1999-11-30
CA2156493A1 (en) 1994-09-01
DE69434239D1 (de) 2005-02-17
DE69434239T2 (de) 2006-03-30
DE69430732D1 (de) 2002-07-11
PT1159965E (pt) 2005-03-31
NZ262998A (en) 1997-06-24
CZ205095A3 (en) 1996-01-17
BG99867A (bg) 1996-04-30
EP1159965A3 (en) 2002-05-22
KR960700726A (ko) 1996-02-24
HUT72079A (en) 1996-03-28
PL175440B1 (pl) 1998-12-31
DE69430732T2 (de) 2002-10-24
AU6299294A (en) 1994-09-14
RU2139055C1 (ru) 1999-10-10
SK282068B6 (sk) 2001-10-08
FI114687B (fi) 2004-12-15
HU221162B1 (en) 2002-08-28
ES2231356T3 (es) 2005-05-16
DK1159965T3 (da) 2005-05-23
CZ294325B6 (cs) 2004-11-10
PT684825E (pt) 2002-10-31
NO953242L (no) 1995-08-17
EP1159965B1 (en) 2005-01-12
FI953878A (fi) 1995-08-17
KR100232833B1 (ko) 1999-12-01
SK101395A3 (en) 1997-04-09
FI953878A0 (fi) 1995-08-17
JPH08510992A (ja) 1996-11-19
ATE286734T1 (de) 2005-01-15
EP0684825B1 (en) 2002-06-05
RO118565B1 (ro) 2003-07-30
JP3054780B2 (ja) 2000-06-19
EP1159965A2 (en) 2001-12-05
ATE218347T1 (de) 2002-06-15
EP0684825A4 (en) 1998-01-14
DK0684825T3 (da) 2002-07-15
EP0684825A1 (en) 1995-12-06
AU692150B2 (en) 1998-06-04
WO1994018982A1 (en) 1994-09-01
PL310357A1 (en) 1995-12-11
US5516769A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
FR2656521B1 (fr) Procede et dispositif pour melanger et administrer directement au point d'application un ciment osseux constitue de deux composes.
FR2711505B1 (fr) Dispositif de synthèse des fractures de l'extrémité supérieure du fémur.
BR9609035A (pt) Anticorpos monoclonais de macaco específicos para formas primatizadas B7.1 e/ou B&.2 humanas composições farmacéuticas
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
FI941396A0 (fi) Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten
DK0384349T3 (da) Substituerede pyrroler
NO930817D0 (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
ES2114605T3 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
NO179062C (no) Koplingsring for todelt ostomi-anordning
DE69425655D1 (de) Antagonisten des fibrinogenrezeptors
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
NO307916B1 (no) Anvendelse av en progesteronreseptorantagonist og kit med innhold derav
IT1282724B1 (it) Cementi portland al calcare
EP0467365A3 (en) Use of a 5-hydroxytryptamine-3(5-ht3) receptor antagonist for the preparation of a pharmaceutical composition for treating urinary incontinence
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
PH18222A (en) 3-(lh-tetrazol-5-yl)-4(3h)aminozolinones and method of use thereof
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
IT1243341B (it) Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
DE3851855D1 (de) Gegen die Gamma-Kette des T-Zell-Rezeptors gerichteter monoklonaler Antikörper.
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
Svatovskaya et al. Clinker and slag alites
ITRM910963A1 (it) Composizione farmaceutica effervescente anticefalalgica e suo impiego
FR2655821B1 (fr) Dispositif et procede de fabrication de biscuits et composition entrant dans cette fabrication.
PE105899A1 (es) Progestagenos cristalinos

Legal Events

Date Code Title Description
MK1K Patent expired